A Study of AK130 in Patients With Advanced Malignant Tumors
NCT05653284
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Malignant Tumors
Interventions
DRUG:
AK130
Sponsor
Akeso